• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎死亡率升高与合并症相关:低收入和中等收入国家与高收入国家的比较

Higher coronavirus disease-19 mortality linked to comorbidities: A comparison between low-middle income and high-income countries.

作者信息

Jindal Har Ashish, Sahoo Soumya Swaroop, Jamir Limalemla, Kedar Ashwini, Sharma Sugandhi, Bhatt Bhumika

机构信息

Senior Consulatant, Ministry of Health and Family Welfare, New Delhi, India.

Department of Community and Family Medicine, All India Institute of Medical Sciences, Bathinda, Punjab, India.

出版信息

J Educ Health Promot. 2021 Oct 29;10:377. doi: 10.4103/jehp.jehp_142_21. eCollection 2021.

DOI:10.4103/jehp.jehp_142_21
PMID:34912913
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8641710/
Abstract

BACKGROUND

Global burden of disease (GBD) provides the estimates of mortality and morbidity, while case fatality rate (CFR) helps in understanding the severity of the disease. People infected with severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) with underlying medical conditions have shown higher levels of unfavorable outcomes including mortality. We assessed the association of SARS-CoV-2 CFR with disability-adjusted life years (DALY) of various comorbidities in the low-middle income countries (LMIC) and high-income countries (HIC) to study the relationship of coronavirus disease-19 (COVID-19) mortality with GBDs and to understand the linkage between COVID-19 mortality and comorbidities.

MATERIALS AND METHODS

This was an ecological study with secondary data analysis comparing the DALY of various morbidities from GBD with CFR of COVID-19. Gross domestic product was the basis of stratifying 177 countries into low-middle income (LMIC) and high-income groups (HIC). The mortality was analyzed using Pearson correlation and linear regression.

RESULTS

The median global CFR of SARS-CoV-2 was 2.15. The median CFR among LMIC ( = 60) and HIC ( = 117) was 2.01 (0.00-28.20) and 2.29 (0.00-17.26), respectively. The regression analysis found that, in both LMIC and HIC, maternal disorders were associated with higher SARS-CoV-2 CFR, while tuberculosis, mental health disorders, and were associated with lower CFR. Further, in LMIC, musculoskeletal disorders and nutritional deficiencies were associated with higher CFR, while respiratory disorders were associated with lower CFR.

CONCLUSIONS

SARS-CoV-2 infection appears to be a systemic disease. Individuals with comorbidities, such as maternal disorders, neurological diseases, musculoskeletal disorders, and nutritional deficiencies, have poorer outcomes with COVID-19, leading to higher mortality.

摘要

背景

全球疾病负担(GBD)提供了死亡率和发病率的估计值,而病死率(CFR)有助于了解疾病的严重程度。感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)且有基础疾病的人出现包括死亡在内的不良结局的水平更高。我们评估了低收入和中等收入国家(LMIC)及高收入国家(HIC)中SARS-CoV-2病死率与各种合并症的伤残调整生命年(DALY)之间的关联,以研究冠状病毒病19(COVID-19)死亡率与全球疾病负担之间的关系,并了解COVID-19死亡率与合并症之间的联系。

材料与方法

这是一项生态研究,通过二次数据分析比较了GBD中各种疾病的DALY与COVID-19的病死率。国内生产总值是将177个国家分为低收入和中等收入(LMIC)组及高收入组(HIC)的依据。使用Pearson相关性和线性回归分析死亡率。

结果

SARS-CoV-2的全球病死率中位数为2.15。LMIC(n = 60)和HIC(n = 117)中的病死率中位数分别为2.01(0.00 - 28.20)和2.29(0.00 - 17.26)。回归分析发现,在LMIC和HIC中,孕产妇疾病均与较高的SARS-CoV-2病死率相关,而结核病、精神健康障碍则与较低的病死率相关。此外,在LMIC中,肌肉骨骼疾病和营养缺乏与较高的病死率相关,而呼吸系统疾病与较低的病死率相关。

结论

SARS-CoV-2感染似乎是一种全身性疾病。患有合并症的个体,如孕产妇疾病、神经系统疾病、肌肉骨骼疾病和营养缺乏,在感染COVID-19时预后较差,导致更高的死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c9/8641710/d37534c0ad58/JEHP-10-377-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c9/8641710/dbff7b5b0056/JEHP-10-377-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c9/8641710/d37534c0ad58/JEHP-10-377-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c9/8641710/dbff7b5b0056/JEHP-10-377-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c9/8641710/d37534c0ad58/JEHP-10-377-g002.jpg

相似文献

1
Higher coronavirus disease-19 mortality linked to comorbidities: A comparison between low-middle income and high-income countries.新型冠状病毒肺炎死亡率升高与合并症相关:低收入和中等收入国家与高收入国家的比较
J Educ Health Promot. 2021 Oct 29;10:377. doi: 10.4103/jehp.jehp_142_21. eCollection 2021.
2
The global burden of hemorrhagic stroke: a summary of findings from the GBD 2010 study.出血性中风的全球负担:全球疾病负担研究2010的结果总结
Glob Heart. 2014 Mar;9(1):101-6. doi: 10.1016/j.gheart.2014.01.003.
3
Mortality Rates of Coronavirus Disease 2019 (COVID-19) Caused by the Novel Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2).新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的2019冠状病毒病(COVID-19)死亡率
Cureus. 2021 Mar 24;13(3):e14081. doi: 10.7759/cureus.14081.
4
Case fatality rates of COVID-19 across the globe: are the current draconian measures justified?全球新冠肺炎病死率:当前的严厉措施是否合理?
Z Gesundh Wiss. 2022;30(11):2575-2583. doi: 10.1007/s10389-021-01491-4. Epub 2021 Mar 24.
5
The differential impact of pediatric COVID-19 between high-income countries and low- and middle-income countries: A systematic review of fatality and ICU admission in children worldwide.高收入国家与中低收入国家儿童 COVID-19 之间的差异影响:全球儿童病死率和 ICU 入院率的系统评价。
PLoS One. 2021 Jan 29;16(1):e0246326. doi: 10.1371/journal.pone.0246326. eCollection 2021.
6
Health inequality among different economies during early phase of COVID-19 pandemic.新冠疫情早期不同经济体之间的健康不平等。
J Egypt Public Health Assoc. 2021 Feb 17;96(1):3. doi: 10.1186/s42506-021-00067-0.
7
Excess Mortality from Mental, Neurological, and Substance Use Disorders in the Global Burden of Disease Study 2010《2010年全球疾病负担研究中精神、神经和物质使用障碍导致的超额死亡率》
8
The Burden of Malnutrition and Fatal COVID-19: A Global Burden of Disease Analysis.营养不良与致命性新冠肺炎负担:一项全球疾病负担分析
Front Nutr. 2021 Jan 21;7:619850. doi: 10.3389/fnut.2020.619850. eCollection 2020.
9
The global case fatality rate of coronavirus disease 2019 by continents and national income: A meta-analysis.按大洲和国民收入划分的2019冠状病毒病全球病死率:一项荟萃分析。
J Med Virol. 2022 Jun;94(6):2402-2413. doi: 10.1002/jmv.27610. Epub 2022 Feb 25.
10
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study.全球死亡率、残疾率及风险因素的影响:全球疾病负担研究
Lancet. 1997 May 17;349(9063):1436-42. doi: 10.1016/S0140-6736(96)07495-8.

引用本文的文献

1
Vitamin B Therapy, Methionine Synthase and Cystathionine Beta-Synthase (CBS) Gene Polymorphisms, and Their Impact on Homocysteine and Cardiovascular Events in Ischemic Stroke With Normal Renal Function: A Randomized Controlled Trial.维生素B疗法、甲硫氨酸合成酶和胱硫醚β合成酶(CBS)基因多态性及其对肾功能正常的缺血性卒中患者同型半胱氨酸水平和心血管事件的影响:一项随机对照试验
Cureus. 2025 Jun 25;17(6):e86727. doi: 10.7759/cureus.86727. eCollection 2025 Jun.
2
Dynamic antibody response in SARS-CoV-2 infected patients and COVID-19 vaccine recipients alongside vaccine effectiveness in comorbid and multimorbid groups.新型冠状病毒感染患者和新冠疫苗接种者的动态抗体反应以及合并症和多种合并症群体中的疫苗有效性。
Heliyon. 2023 May 20;9(5):e16349. doi: 10.1016/j.heliyon.2023.e16349. eCollection 2023 May.
3

本文引用的文献

1
Social influence of COVID-19: An observational study on the social impact of post-COVID-19 lockdown on everyday life in Kerala from a community perspective.新冠疫情的社会影响:从社区视角对喀拉拉邦解除新冠疫情封锁后对日常生活的社会影响进行的观察性研究。
J Educ Health Promot. 2020 Dec 29;9:360. doi: 10.4103/jehp.jehp_650_20. eCollection 2020.
2
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies.COVID-19 重症患者中中剂量与标准剂量预防性抗凝和他汀类药物治疗与安慰剂对照的研究:INSPIRATION/INSPIRATION-S 研究的原理和设计。
Thromb Res. 2020 Dec;196:382-394. doi: 10.1016/j.thromres.2020.09.027. Epub 2020 Sep 24.
3
Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial.TURKOVAC与科兴新冠疫苗两剂接种方案在健康受试者中的有效性、免疫原性和安全性:一项随机、观察者盲法、非劣效性III期试验
Vaccines (Basel). 2022 Nov 4;10(11):1865. doi: 10.3390/vaccines10111865.
4
World Lung Day: impact of "the big 5 lung diseases" in the context of COVID-19.世界肺病日:“五大肺病”在新冠疫情背景下的影响
Am J Physiol Lung Cell Mol Physiol. 2022 Sep 1;323(3):L338-L340. doi: 10.1152/ajplung.00261.2022. Epub 2022 Aug 16.
5
Syndemics and clinical science.综合征与临床科学。
Nat Med. 2022 Jul;28(7):1359-1362. doi: 10.1038/s41591-022-01888-y. Epub 2022 Jul 21.
Exposure to coronavirus (COVID-19) using narrative and simulated experience approaches: A commentary.采用叙事和模拟体验方法接触冠状病毒(COVID-19):一篇评论。
J Educ Health Promot. 2020 Jun 30;9:135. doi: 10.4103/jehp.jehp_267_20. eCollection 2020.
4
Effectiveness of hydroxychloroquine in COVID-19 disease: A done and dusted deal?羟氯喹在新冠病毒疾病中的有效性:已成定局?
Int J Infect Dis. 2020 Oct;99:75-76. doi: 10.1016/j.ijid.2020.07.056. Epub 2020 Jul 29.
5
Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19.羟氯喹、阿奇霉素和联合治疗 COVID-19 住院患者。
Int J Infect Dis. 2020 Aug;97:396-403. doi: 10.1016/j.ijid.2020.06.099. Epub 2020 Jul 2.
6
Role of vitamin D in preventing of COVID-19 infection, progression and severity.维生素 D 在预防 COVID-19 感染、进展和严重程度中的作用。
J Infect Public Health. 2020 Oct;13(10):1373-1380. doi: 10.1016/j.jiph.2020.06.021. Epub 2020 Jun 20.
7
Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-June 7, 2020.美国 2020 年 1 月 22 日-6 月 7 日,按妊娠状况划分的实验室确诊感染 SARS-CoV-2 的育龄期妇女特征。
MMWR Morb Mortal Wkly Rep. 2020 Jun 26;69(25):769-775. doi: 10.15585/mmwr.mm6925a1.
8
Neurological involvement of coronavirus disease 2019: a systematic review.新型冠状病毒肺炎的神经系统表现:一项系统评价。
J Neurol. 2020 Nov;267(11):3135-3153. doi: 10.1007/s00415-020-09990-2. Epub 2020 Jun 19.
9
Maternal Mortality From Coronavirus Disease 2019 (COVID-19) in the United States.美国 2019 冠状病毒病(COVID-19)导致的孕产妇死亡。
Obstet Gynecol. 2020 Aug;136(2):313-316. doi: 10.1097/AOG.0000000000004024.
10
Coronavirus disease 2019 in children: Current status.儿童 2019 年冠状病毒病:现状。
J Chin Med Assoc. 2020 Jun;83(6):527-533. doi: 10.1097/JCMA.0000000000000323.